Has Robyn Siperstein, MD received payments from drug or device companies?

Yes. Drug and device makers reported $753,637 in general payments to Robyn Siperstein, MD across 594 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robyn Siperstein, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robyn Siperstein, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robyn Siperstein, MD

Dermatology · Boynton Beach, FLNPI 1154422327

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $494,374 of the $753,637 with a category attached, or 65.6%. AbbVie accounts for 72.0% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $185,089 and has fallen 62.9% since, to $68,576 in 2025. Among dermatology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$753,637in general payments, 2019–2025

Across 594 payments — averaging $1268.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$542K
Galderma Laboratories, L.p.$210K
Sanofi$148
E.r. Squibb & Sons, L.L.C.$121
Revance Therapeutics, Inc.$99
Johnson & Johnson$84
plus $448 from 14 others

$168,988in research payments, 2019–2025

Across 10 payments — averaging $16,899 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AbbVie$135K
Avita Medical Americas, LLC$34K

What the payments were for

Consulting fees$106,41214%
Speaking & faculty fees$494,37466%
Grants$93,29512%
Travel & lodging$46,4326%
Food & beverage$12,9652%
Education$1590%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	454	$542,276
Galderma Laboratories, L.p.	110	$210,461
Sanofi	5	$148
E.r. Squibb & Sons, L.L.C.	1	$121
Revance Therapeutics, Inc.	1	$99
Johnson & Johnson	4	$84
Merz North America, Inc.	1	$65
Endo Pharmaceuticals Inc.	2	$61
Regeneron Healthcare Solutions, Inc.	2	$46
DUSA Pharmaceuticals, Inc.	2	$40
Verrica Pharmaceuticals Inc.	2	$38
Novartis	2	$37
Boehringer Ingelheim	1	$28
Incyte Corporation	1	$26
Medimetriks Pharmaceuticals, Inc.	1	$25
LEO Pharma Inc.	1	$23
Sun Pharmaceutical Industries Inc.	1	$19
Aclaris Therapeutics, Inc.	1	$17
Biofrontera Inc.	1	$14
Sensus Healthcare, Inc.	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BOTOX$424,411
BOTOX COSMETIC$6,524
KYBELLA$1,950
NATRELLE SALINE-FILLED BREAST IMPLANTS$293
DYSPORT$175
Sotyktu$121

How this compares

$753,637 in reported general payments places this provider in the 95th percentile of 1,147 dermatology providers in Florida.

See all dermatology providers in Florida →

Medicare billing

Part B allowed, 2024

$556,795

Medicare patients

3,094

Services billed

6,698

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ValacyclovirValacyclovir Hcl	22	$865

Paid to pharmacies, not to this prescriber.

Other dermatology in Boynton Beach

Julian Mackay-WigganBoynton Beach$172K
Francisco KerdelMiami$2.1M
Brad GlickMargate$2M
Robert KirsnerMiami$1.4M
John MinniStuart$1.4M
Gil YosipovitchMiami$1M
Shino Bay AguileraFt Lauderdale$1M
Robert SnyderPembroke Pines$1M
Marc IngleseTallahassee$989K
Jeremy GreenCoral Gables$952K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →